Fig. 4: RSPO2 and RSPO3 interact with BMPR1A via the TSP1 domain. | Nature Communications

Fig. 4: RSPO2 and RSPO3 interact with BMPR1A via the TSP1 domain.

From: R-spondins are BMP receptor antagonists in Xenopus early embryonic development

Fig. 4

a–c BRE reporter assays in HEPG2 cells transfected with constitutively active (QD) BMPR1A (a), ACVR1 (b), or BMPR1B (c) with or without BMP4 and RSPO1-4 treatment overnight. d Cell surface binding assay in HEK293T cells. (Left) Scheme of the assay. Cells were transfected with BMPR1A or LGR4 DNA, and treated with same amount of RSPO1-4-AP upon DSP crosslinking as indicated. Binding was detected as purple stain on cell surface by chromogenic AP assay. (Right) Images of cells transfected and treated as indicated. Data shows a representative from four independent experiments. For quantification, see Supplementary Fig. 5a. Scale bar, 1 mm. e In vitro binding assay between RSPO1-4, FGF and BMPR1AECD. (Left) Scheme of the assay. RSPOs and FGF recombinant proteins were coated on plate as baits, followed by BMPR1AECD-AP treatment overnight. (Right) Bound BMPR1AECD was detected by chromogenic AP assay. Normalized AP activity with control treatment was set to 1. f Scatchard plot of RSPO2 and BMPR1AECD binding to validate Kd for RSPO2-BMPR1A. g Domain structures of the RSPO1 and RSPO2TSP1 with Strep-HA and flag tags used in h. SP, signal peptide; TSP1, thrombospondin domain 1. h In vitro binding assay for RSPOTSP1 and BMPR1AECD. (Left) Scheme of the assay. HA-harboring RSPO1/2TSP1 were captured to HA antibody coated plate, and BMPR1AECD-AP was treated overnight. (Right) Bound BMPR1A to RSPOTSP1 was detected with absorbance. i Domain structures of the RSPO1, RSPO2, and R1-TSPR2. SP, signal peptide; FU, furin domain; TSP1, thrombospondin domain 1. Dashed box indicates the TSP1 domain swapping. j TOPFlash reporter assay in HEPG2 cells upon WNT3A with or without (i) as indicated. k BRE reporter assay in HEPG2 cells upon BMP4 with or without (i) as indicated. For reporter assays (a–c, j, k), n = 3 biologically independent samples; In vitro binding assays (e, h), n = 3 experimentally independent samples. All data are displayed as mean ± SD. ns, not significant, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 from two-tailed unpaired t-test (a, b, e, h, j, k) or one-way ANOVA test (c).

Back to article page